基于增强MRI的影像组学列线图术前预测巨梁索型-巨块型肝细胞癌
本研究纳入88例经组织学确诊的肝细胞癌患者(32例MTM-HCC,56例非MTM-HCC),回顾性分析钆贝葡胺增强MRI特征并提取影像组学特征构建列线图。MTM-HCC患者Rad-score显著更高,影像组学评分(OR=7.794)和瘤内脂肪(OR=9.963)为独立预测因子,模型AUC为0.813(95%CI 0.714-0.912),列线图AUC为0.785(95%CI 0.684-0.886)。
要点
- MTM-HCC患者MRI影像组学评分(Rad-score)显著高于非MTM-HCC(P<0.001)。
- 瘤内脂肪是MTM-HCC的独立预测影像因子(OR=9.963,P=0.014)。
- 基于增强MRI的影像组学列线图术前预测MTM-HCC的AUC为0.785。
关键影像表现/征象
- MTM-HCC患者Rad-score绝对值总体高于非MTM-HCC患者(P<0.001)。
- 多因素分析显示影像组学评分(OR=7.794,P<0.001)和瘤内脂肪(OR=9.963,P=0.014)为MTM-HCC独立预测因子。
诊断标准与关键数值
- 所选模型ROC曲线下面积AUC为0.813(95%CI 0.714-0.912),最佳截断值为0.60。
- 列线图总体预测性能AUC为0.785(95%CI 0.684-0.886),校准曲线显示满意。
临床应用与阅片要点
- 阅片时可关注瘤内脂肪征象,并结合影像组学评分辅助术前识别MTM-HCC。
- 列线图最佳截断值为0.60,可作为术前风险评估的参考阈值。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Macrotrabecular-massive hepatocellular carcinoma (MTM-HCC) represents an aggressive form of hepatocellular carcinoma and is associated with poor survival outcomes.
AIMS: This study aimed to develop a radiomics nomogram based on contrast-enhanced MRI for preoperative prediction of MTM-HCC.
METHODS: This study enrolled 88 patients with histologically confirmed HCC, including 32 MTM-HCCs and 56 Non-MTM-HCCs. The clinical and gadobenate dimeglumine (Gd)-enhanced MRI features were retrospectively reviewed by two abdominal radiologists. The regions of interest (ROIs) on the largest cross-sectional image and two adjacent images of the tumor, from which radiomics features were extracted via MaZda software and a radiomics score (Rad-score) was calculated via Python software. Combined with the Rad-score and independent imaging factors, a radiomics nomogram was constructed using R software. Nomogram performance was estimated with calibration curve.
RESULTS: A total of eleven top weighted radiomics features were selected among five sequences of MR images. There was a significant difference in Rad-score between MTM-HCC and non-MTM-HCC patients (P < 0.001), where patients with MTM-HCC generally had higher Rad-scores (absolute value). After multivariate analysis, radiomics score (OR = 7.794, P < 0.001) and intratumor fat (OR = 9.963, P = 0.014) were determined as independent predictors associated with MTM-HCC. The area under the receiver operating characteristic (ROC) curve of the selected model was 0.813 (95% CI 0.714-0.912) and the optimal cutoff value was 0.60. The nomogram showed overall satisfactory prediction performance (AUC = 0.785 [95% CI 0.684-0.886]).
CONCLUSIONS: A contrast-enhanced MRI-based radiomics nomogram may be useful for preoperative prediction of MTM-HCC in primary HCC patients, allowing opportunity to improve the treatment course and patient outcomes.
引用
- Zhu Y, Weng S, Li Y, et al. A radiomics nomogram based on contrast-enhanced MRI for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma. Abdom Radiol (NY). 2021. PMID: 33641018. doi:10.1007/s00261-021-02989-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。